During the past decade, Meltem Savran Karadeniz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Meltem Savran Karadeniz" are "Acute Hyponatremia" (1 trials), "Anesthesia" (1 trials), "Postoperative Pain, Acute" (1 trials) and "Regional Anesthesia" (1 trials). Many other conditions were trialed in "Meltem Savran Karadeniz" in a lesser frequency.

Most popular intervention types in "Meltem Savran Karadeniz" are "Device" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0,9% Sodium chloride" (1 trials), "5% Mannitol" (1 trials), "Bupivacaine 0.25% Injectable Solution" (1 trials), "Infraclavicular brachial plexus block" (1 trials) and "bipolar resectoscope TURis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meltem Savran Karadeniz" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Meltem Savran Karadeniz". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Meltem Savran Karadeniz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Meltem Savran Karadeniz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".